Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

Roche and Prothena set to advance Parkinson’s disease candidate into phase 2b

Roche and Prothena set to advance Parkinson’s disease candidate into phase 2b Roche and biotech company Prothena are set to advance their Parkinson’s disease candidate prasinezumab into a phase 2b efficacy trial following some promising results in an earlier trial. ... In 2013, Roche and Prothena entered a collaboration

Roche to collaborate with Dyno on gene therapies for CNS/liver diseases

Roche to collaborate with Dyno on gene therapies for CNS/liver diseases Swiss pharma giant Roche has partnered with Cambridge, Massachusetts-based Dyno Therapeutics for the development of gene therapies for central nervous system (CNS) and liver diseases. ... The Roche deal is Dyno’s third pharma collaboration, in addition

Finalists

LiverSync. by Norgine. with support from earthware. #PutCancerToTheTest. by Roche. with support from Galliard Healthcare Communications. ... The What If? Accelerator. by Roche. with support from Virgo Health.

Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail

Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail In August, Regeneron also signed a deal with Roche to bolster manufacturing and global development capabilities for the antibody cocktail. ... The collaboration is expected to increase the supply of REGN-COV2 by at least three and a half times its

BMS’ Opdivo is first immunotherapy to score phase 3 win in pre-surgery NSCLC

BMS’ Opdivo is first immunotherapy to score phase 3 win in pre-surgery NSCLC This means it beats a number of competitors to the punch – including Merck &Co’s Keytruda (pembrolizumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab), which are all studying their ... This includes Roche’s Tecentriq,

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics